United States (US) Genome Editing Market (2025-2031) | Segmentation, Analysis, Share, Forecast, Industry, Value, Companies, Competitive Landscape, Size & Revenue, Growth, Trends, Outlook

Market Forecast By Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-like Effector Nuclease (TALEN), Zinc Finger Nuclease (ZFN), Other Technologies), By Application (Cell Line Editing, Animal Genome Editing, Plant Genome Editing, Others), By End-user (Pharmaceutical Companies and Biotechnology Companies, Academics and Government Research Institutes, Clinical Research Organizations) And Competitive Landscape
Product Code: ETC9966886 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Dhaval Chaurasia No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Genome Editing Market Outlook
  • Market Size of United States (US) Genome Editing Market, 2024
  • Forecast of United States (US) Genome Editing Market, 2031
  • Historical Data and Forecast of United States (US) Genome Editing Revenues & Volume for the Period 2021- 2031
  • United States (US) Genome Editing Market Trend Evolution
  • United States (US) Genome Editing Market Drivers and Challenges
  • United States (US) Genome Editing Price Trends
  • United States (US) Genome Editing Porter's Five Forces
  • United States (US) Genome Editing Industry Life Cycle
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Technology for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Transcription Activator-like Effector Nuclease (TALEN) for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Zinc Finger Nuclease (ZFN) for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Other Technologies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Cell Line Editing for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Animal Genome Editing for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Plant Genome Editing for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By End-user for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Pharmaceutical Companies and Biotechnology Companies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Academics and Government Research Institutes for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Genome Editing Market Revenues & Volume By Clinical Research Organizations for the Period 2021- 2031
  • United States (US) Genome Editing Import Export Trade Statistics
  • Market Opportunity Assessment By Technology
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By End-user
  • United States (US) Genome Editing Top Companies Market Share
  • United States (US) Genome Editing Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Genome Editing Company Profiles
  • United States (US) Genome Editing Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Genome Editing Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Genome Editing Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Genome Editing Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Genome Editing Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Genome Editing Market - Industry Life Cycle

3.4 United States (US) Genome Editing Market - Porter's Five Forces

3.5 United States (US) Genome Editing Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 United States (US) Genome Editing Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United States (US) Genome Editing Market Revenues & Volume Share, By End-user, 2021 & 2031F

4 United States (US) Genome Editing Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investments in research and development in the field of genome editing

4.2.2 Rising prevalence of genetic disorders and chronic diseases driving the demand for genome editing technologies

4.2.3 Technological advancements leading to the development of more efficient and precise genome editing tools

4.3 Market Restraints

4.3.1 Ethical concerns surrounding genome editing, particularly in the context of germline editing

4.3.2 Stringent regulatory requirements and uncertainty in the regulatory landscape for genome editing technologies

5 United States (US) Genome Editing Market Trends

6 United States (US) Genome Editing Market, By Types

6.1 United States (US) Genome Editing Market, By Technology

6.1.1 Overview and Analysis

6.1.2 United States (US) Genome Editing Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 United States (US) Genome Editing Market Revenues & Volume, By Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), 2021- 2031F

6.1.4 United States (US) Genome Editing Market Revenues & Volume, By Transcription Activator-like Effector Nuclease (TALEN), 2021- 2031F

6.1.5 United States (US) Genome Editing Market Revenues & Volume, By Zinc Finger Nuclease (ZFN), 2021- 2031F

6.1.6 United States (US) Genome Editing Market Revenues & Volume, By Other Technologies, 2021- 2031F

6.2 United States (US) Genome Editing Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Genome Editing Market Revenues & Volume, By Cell Line Editing, 2021- 2031F

6.2.3 United States (US) Genome Editing Market Revenues & Volume, By Animal Genome Editing, 2021- 2031F

6.2.4 United States (US) Genome Editing Market Revenues & Volume, By Plant Genome Editing, 2021- 2031F

6.2.5 United States (US) Genome Editing Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Genome Editing Market, By End-user

6.3.1 Overview and Analysis

6.3.2 United States (US) Genome Editing Market Revenues & Volume, By Pharmaceutical Companies and Biotechnology Companies, 2021- 2031F

6.3.3 United States (US) Genome Editing Market Revenues & Volume, By Academics and Government Research Institutes, 2021- 2031F

6.3.4 United States (US) Genome Editing Market Revenues & Volume, By Clinical Research Organizations, 2021- 2031F

7 United States (US) Genome Editing Market Import-Export Trade Statistics

7.1 United States (US) Genome Editing Market Export to Major Countries

7.2 United States (US) Genome Editing Market Imports from Major Countries

8 United States (US) Genome Editing Market Key Performance Indicators

8.1 Number of clinical trials utilizing genome editing technologies in the US

8.2 Adoption rate of CRISPR/Cas9 and other genome editing tools in research institutions and biotech companies

8.3 Number of partnerships and collaborations between academic institutions, biotech firms, and pharmaceutical companies for genome editing research and development

9 United States (US) Genome Editing Market - Opportunity Assessment

9.1 United States (US) Genome Editing Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 United States (US) Genome Editing Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United States (US) Genome Editing Market Opportunity Assessment, By End-user, 2021 & 2031F

10 United States (US) Genome Editing Market - Competitive Landscape

10.1 United States (US) Genome Editing Market Revenue Share, By Companies, 2024

10.2 United States (US) Genome Editing Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Latest Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence